Retatrutide (Reta) 40 mg approved vial
Weight Loss

Retatrutide (Reta) — 40 mg, 20 mg, 10 mg, 30 mg

Retatrutide (Reta) is the "triple agonist": it targets GLP-1, GIP and glucagon receptors at once, one step beyond semaglutide and tirzepatide research.

Key researched benefits

  • Up to 24% average weight loss in a 48-week trial, among the largest results seen in this research class
  • Liver fat dropped by up to 86% in trial participants, with most reaching normal levels
  • Studied for less hunger, feeling full for longer and burning more stored fat for energy
  • Better blood sugar and insulin response seen in metabolic studies
  • Lower cholesterol, triglycerides and blood pressure reported in trial data
  • Growing research into heart health, brain health (including dementia risk) and healthy ageing

Summarised from published laboratory and animal research. Not medical advice.

Sizes and pricing

  • RT4040 mg$202.50In stock
  • RT2020 mg$115In stock
  • RT1010 mg$80In stock
  • RT3030 mg$190Sold out

Prices in CAD and subject to change. $20 flat shipping across Canada, free over $300 after discounts.

Specifications

  • Advertised purity

    99+%

  • Fill

    95%+ of stated weight

  • Presentation

    Lyophilized powder in a sealed vial

  • Storage

    Reconstituted vials store at 2°C–8°C | New sealed vials 6+ months store in freezer

  • Documentation

    Backed by the manufacturer, EnhancedHealth' own COAs, and client third-party testing

  • Independent testing

    Janoshik or Freedom Diagnostics welcome

Certificate of Analysis

Every peptide we stock is backed by its manufacturer, EnhancedHealth ' own COAs, and client third-party testing. This product's certificate is not currently published online. See all published certificates.

Research use only

Inquire or add to your order